The role of the nurse practitioner in autologous chondrocyte implantation of the knee

SummaryThis paper provides an overview of autologous chondrocyte implantation for the repair of full-thickness articular cartilage defects in the knee, the benefits and risks associated with the procedure, financial considerations, issues surrounding the surgery, and the role of the nurse practitioner. The procedure was first introduced in the United States (US) in 1995 with subsequent Food and Drug Administration (FDA) approval in 1997. It is one of the newest treatments available to orthopaedic patients who suffer from articular cartilage damage. When deciding on whether the procedure is appropriate for the patient a number of factors need to be considered, including the patient’s financial state. The nurse practitioner plays a key role in evaluating patients, providing education, assisting in surgery, and providing post-operative care.